VExUS Score and AKI in Critically Ill Adult patients-a Prospective Observational Study.
Correlation of Point of Care Venous Excess Ultrasonography (VExUS) Score and Acute Kidney Injury (AKI) in Critically Ill Adult Patients- a Prospective Observational Study.
1 other identifier
observational
52
1 country
1
Brief Summary
Introduction Renal perfusion is dependent on the renal perfusion pressure across the renal capillaries. Venous congestion due to excess fluid therapy can drastically reduce the renal perfusion pressure in spite of a normal mean arterial pressure. Increasing cumulative fluid balance during the ICU stay has been found to be associated with negative outcomes including acute kidney injury (AKI) and hospital mortality. Venous excess ultrasound (VExUS) to assess the Doppler studies of renal, hepatic and portal veins along with the inferior venacava has been shown to reliably predict the incidence of AKI in certain ICU patient population more specifically in cardiorenal syndrome. The aim of this study was to correlate the incidence of AKI and VExUS scores in a mixed ICU population and hence determine the contribution of venous congestion on the causation of AKI in a general ICU. Methods: The patients included who have AKI at admission or developed AKI during their ICU stay were included. The definition of AKI used for this study was as defined by Kidney Disease: Improving Global Outcomes (KDIGO). Point of care VExUS scans were done on each patient at inclusion (day 0), then each day for a total of 4 days (day 1, 2 and 3), till initiation of renal replacement therapy, death or discharge form the ICU. Correlation between VExUS grades and creatinine clearances was explored as the primary objective.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 7, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 11, 2024
CompletedFirst Submitted
Initial submission to the registry
March 15, 2025
CompletedFirst Posted
Study publicly available on registry
March 21, 2025
CompletedMarch 21, 2025
March 1, 2025
8 months
March 15, 2025
March 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To determine correlation between the VExUS score with creatinine clearance.
At the end of Day 3 or initiation of renal replacement therapy or resolution of AKI, death or discharge from the ICU. whichever came first.
Study Arms (1)
Patients with AKI
Patients who are admitted with the diagnosis of AKI or develop AKI during their ICU stay
Eligibility Criteria
Patients who had AKI at the time of admission or who developed AKI during their ICU stay were screened for inclusion.
You may qualify if:
- Age ≥18 years
- Admitted to the adult ICUs of TUTH (ICU A and ICU B)
- Admitting diagnosis of AKI or who developed AKI during their ICU stay
You may not qualify if:
- Pregnancy
- Diagnosed case of chronic kidney disease
- Diagnosed case of cirrhosis/ portal hypertension
- Arrhythmias which would interfere with the acquisition and interpretation of the Doppler waveforms
- Inferior venacava thrombus
- Poor window for assessment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tribhuvan University Teaching Hospital
Mahārājgañj, Bagmati, 44600, Nepal
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle investigator
Study Record Dates
First Submitted
March 15, 2025
First Posted
March 21, 2025
Study Start
May 15, 2023
Primary Completion
January 7, 2024
Study Completion
January 11, 2024
Last Updated
March 21, 2025
Record last verified: 2025-03